Hera Biotech, Inc. — Form D/A
Hera Biotech, Inc. of SAN ANTONIO, TX, a company, filed a Form D amendment with the SEC on 2022-01-28. The offering totals $1.5M, of which $804K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-01-28
- Form: D/A
- Accession: 0001831293-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $804K
- Remaining: $697K
- Investors: 18
- Date of first sale: 2020-11-03
- Revenue range: Decline to Disclose
- SEC file number: 021-380138
Issuer
- Name: Hera Biotech, Inc.
- CIK: 0001831293
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 4725 COLLEGE PARK, SUITE 200, SAN ANTONIO, TX, 78249
- Phone: 2106831069
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Paul Castella | Director | San Antonio, TX |
| Paul Castella | Executive Officer | San Antonio, TX |
| Somer Baburek | Director | San Antonio, TX |
| Somer Baburek | Executive Officer | San Antonio, TX |
| Wendy Smith | Director | San Antonio, TX |
| Neal Walsdorf, Jr. | Director | San Antonio, TX |
Other filings by this issuer (5)
More